Skip to main content
ZC

Zxerex Corporation

The startup provides real-time impairment detection services for marijuana, opioids, and fatigue, utilizing advanced biometric analysis to assess employee fitness for duty without traditional body fluid testing. This technology enhances workplace safety by enabling employers to monitor and manage risks associated with employee impairment effectively.

Scottsdale, United StatesFounded 2016450+ followers
Updated 3 months ago

Funding

$5.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional drug and alcohol testing methods rely on detecting the presence of substances in bodily fluids, which may not accurately reflect an individual's current state of impairment. This creates challenges for employers needing to ensure employees are fit for duty, especially in safety-sensitive roles, as standard tests can detect drug use long after the impairing effects have subsided. Workplace accidents and injuries related to impairment from drugs, alcohol, and fatigue result in significant financial losses for employers.

Solution

ZXEREX provides a technology-driven solution for real-time impairment detection, utilizing neuroscience, AI, and machine learning to assess an individual's fitness for duty without the need for bodily fluid samples. The company's screening process identifies temporary neurological changes in the brain associated with impairment from substances like marijuana and opioids, as well as fatigue and sleep deprivation. By detecting the effects of drugs rather than their presence, ZXEREX offers a more accurate assessment of current impairment levels. This rapid, non-invasive screening can be implemented at the worksite to deter risky behavior, reduce accidents and injuries, and improve overall workplace safety.

Target Audience

The primary target audience includes employers in safety-sensitive industries such as transportation, manufacturing, construction, public safety, and healthcare, seeking to mitigate risks associated with employee impairment.

Features

  • Rapid, non-invasive impairment screening completed in 2-3 minutes
  • AI and machine learning algorithms analyze neurological indicators of impairment
  • Detects impairment from marijuana, opioids, fatigue, and sleep deprivation
  • Cloud-based platform for data analysis and reporting
  • On-site screening services with options for complete care, transitioning care, and self-delivery models
  • Training programs available for managers and supervisors
  • Integration with existing risk management systems (RMS)
This profile is AI-generated and may contain inaccuracies.